Supply, Storage, Over-labelling and Distribution of Ascorbic Acid

Concepts

• pharmaceutical products
• department of health and social care
• department of health
• distribution of ascorbic acid
• social care
• value of that particular contract
• sensitive information
• negotiated procedure
• dhsc
• prior publication

Location

United Kingdom:

Description

The Department of Health and Social Care (DHSC) has awarded contracts for the Supply, Storage, Over-labelling and Distribution of Ascorbic Acid.

Total Quantity or Scope

The Department of Health and Social Care conducted a negotiated procedure without prior publication under the Public Contracts Regulations 2015 (as amended) for the Supply, Storage, Over-labelling and Distribution of Ascorbic Acid. Additional information: Value — the contract awarded to Mawdsley-Brooks, this information is considered by the supplier to be commercially sensitive information. The Authority is not publishing the value of that particular contract so as not to prejudice the legitimate commercial interest of the supplier. As a result, the value shown under V.2.4 only represents the value of the contract awarded to Clinigen.

Award Detail

Award Criteria

CPV Codes

• 33600000 - Pharmaceutical products

Legal Justification

The Coronavirus disease (COVID-19) gave rise to an extremely urgent need for the Authority to purchase a quantity of Ascorbic Acid because the Authority needs to be in a position to treat the population as required such that did not give the Authority sufficient time to comply with the standard Open Procedure time scales for this procurement. Accordingly, the Authority used the negotiated procedure without prior publication – Regulation 32(2)(c) – Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement. It was imperative to maintain security of supply for public health purposes in the face of high global demand. In these circumstances, a procurement following the usual timescales under the PCR 2015, including accelerated options, was not feasible in order for the Authority to secure the urgent Supply, Storage, Over-labelling and Distribution of Ascorbic Acid.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **